Novo-Nordisk (NVO)
Novo Nordisk faces a lawsuit from Hims & Hers over compounded GLP-1 drugs, while also seeing positive developments with Wegovy's cardiovascular benefits and strong demand for its GLP-1 pill.
About Novo-Nordisk
Novo Nordisk is a pharmaceutical company specializing in diabetes and obesity treatments.
Novo-Nordisk uses the ticker $NVO for trading. Listed in the Stocks category within the Healthcare sectors.
Insights
- Novo-Nordisk (NVO) Galaxy Score™ is up 21.62% from the previous week.
- Novo-Nordisk (NVO) sentiment is up 11.67% from the previous week.
Price: $49
Price 24-Hour Time-Series Raw Data
The stock price experienced a significant drop due to weak guidance and competition concerns. However, recent FDA actions against compounded GLP-1 drugs and Novo Nordisk's lawsuit against Hims & Hers have provided some support, leading to a slight post-market uptick.
24-Hour: -1.31% 7-Day: -2.29% 30-Day: -21.45%
1-Year High: $91 on 2025-02-25
1-Year Low: $43.30 on 2026-02-05
AltRank: [---]
AltRank 24-Hour Time-Series Raw Data
Novo-Nordisk (NVO) is currently AltRank #113 based on combined combined social and market metrics
Daily Average: [---]
[--] Week: [---] +33
[--] Month: [--] [---]
[--] Months: [--] [----]
[--] Year: [--] [---]
1-Year High: [-----] on 2025-07-05
1-Year Low: [--] on 2025-03-30
Galaxy Score: [-----]
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] +8
[--] Month: [--] [---]
[--] Months: [--] [---]
[--] Year: [--] [---]
1-Year High: [--] on 2025-06-10
1-Year Low: [--] on 2025-06-25
Engagements: [-------] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [-------]
Daily Average: [-------]
[--] Week: [---------] -71%
[--] Month: [----------] -1.60%
[--] Months: [-----------] +25%
[--] Year: [-----------] +298%
1-Year High: [----------] on 2025-08-26
1-Year Low: [------] on 2025-02-28
Engagements by network (24h): X: [-------] YouTube: [-----] Reddit: [---] TikTok: [------] Instagram: [--]
Mentions: [-----] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [-----]
[--] Week: [-----] -6.60%
[--] Month: [------] +17%
[--] Months: [------] +61%
[--] Year: [-------] +143%
1-Year High: [-----] on 2025-11-07
1-Year Low: [---] on 2025-03-01
Mentions by network (24h): X: [-----] YouTube: [--] Reddit: [--] TikTok: [--] Instagram: [--]
Creators: [---] (24h)
Creators 24-Hour Time-Series Raw Data
[---] unique social accounts have posts mentioning Novo-Nordisk (NVO) in the last [--] hours which is down 20% from [-----] in the previous [--] hours
Daily Average: [---]
[--] Week: [-----] -12%
[--] Month: [-----] +11%
[--] Months: [------] +56%
[--] Year: [------] +146%
1-Year High: [-----] on 2025-11-07
1-Year Low: [---] on 2025-03-01
The most influential creators that mention Novo-Nordisk in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @himshouse | [--] | [------] | [--] | [------] |
| @TheRayMyers | [--] | [------] | [--] | [------] |
| @investseekers | [--] | [-----] | [--] | [------] |
| @novonordisk | [--] | [------] | [--] | [------] |
| @BourbonCap | [--] | [------] | [--] | [------] |
| @MitchMartan98 | [--] | [-----] | [--] | [------] |
| @danielisdizzy | [--] | [------] | [--] | [------] |
| @SiemprePulpo | [--] | [-----] | [--] | [------] |
| @DeepIceValue | [--] | [------] | [--] | [------] |
| @TrendSpider | [--] | [-------] | [--] | [------] |
Sentiment: 65%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 65%
Daily Average: 71%
[--] Week: 67% +7%
[--] Month: 61% -20%
[--] Months: 61% -17%
[--] Year: 61% -10%
1-Year High: 88% on 2025-12-26
1-Year Low: 27% on 2025-09-24
Most Supportive Themes:
- Positive Clinical Trial Results and Wegovy's Cardiovascular Benefits: (35%) Posts highlighting positive results from clinical trials for Novo Nordisk's drugs, particularly Wegovy, and its cardiovascular benefits.
- Long-Term Growth Potential and Valuation: (25%) Posts discussing the long-term growth potential of Novo Nordisk, especially in the obesity and diabetes markets, and its current valuation.
- Expert Analysis and Recommendations: (15%) Posts from analysts and financial experts recommending Novo Nordisk as a buy or highlighting its strengths.
Most Critical Themes:
- Competition and Market Share Concerns: (20%) Posts expressing concerns about increasing competition from other pharmaceutical companies, particularly Eli Lilly, and its impact on Novo Nordisk's market share.
- Negative Guidance and Restructuring: (5%) Posts discussing the company's lowered sales and operating profit outlook, job cuts, and restructuring efforts.
Social Dominance: 0.125%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.125%
Daily Average: 0.216%
[--] Week: 0.126% -0.252%
[--] Month: 0.264% -0.045%
[--] Months: 0.264% -0.034%
[--] Year: 0.264% +0.102%
1-Year High: 0.454% on 2025-11-06
1-Year Low: 0.091% on 2025-12-07
Market Dominance: 0.248%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.248%
Daily Average: 0%
1-Year High: 11.60% on 2025-03-31
1-Year Low: 0.227% on 2026-02-05
Market Cap: $217,533,379,692
Market Cap 24-Hour Time-Series Raw Data
Current Value: $217,533,379,692
Daily Average: $271,954,420,749
[--] Week: $217,711,248,359 -1.70%
[--] Month: $217,711,248,359 -21%
[--] Months: $217,711,248,359 -12%
[--] Year: $217,711,248,359 -37%
1-Year High: $403,731,856,617 on 2025-02-25
1-Year Low: $192,720,700,651 on 2026-02-05
Top Novo-Nordisk Social Posts
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"Sezon wynikw w USA: [--] trendw ktre zmieniaj Wall Street w [----] r. Sezon wynikw w USA zacz si od mocnego bicia oczekiwa ale rynek szybko przerzuci uwag z samych zyskw na ich jako i koszt ich wypracowania. W tle ronie rachunek za AI konsument apie zadyszk elektryki schodz na ziemi w farmacji GLP-1 zmienia si ukad si a energetyka wraca do roli maszynki do gotwki. Oto pi najwaniejszych wnioskw Exante z trwajcego sezonu wynikw w USA. Link do artykuu: ➡https://www.stockwatch.pl/wiadomosci/sezon-wynikow-w-usa-5-trendow-ktore-zmieniaja-wall-street-w-2026-rakcje366309 Artyku jest wynikiem opracowania"
YouTube Link @stockwatchplsw 2026-02-16T18:31Z [----] followers, [---] engagements
"Novo nordisk stocks are collapsing This is a great buy ipportunity #novonordisk"
YouTube Link @forecaster 2024-12-20T12:29Z [----] followers, 12.6K engagements
"How to use NovoPen [--] The video is designed to train HCPs on how to use NovoPen [--] Novo Nordisk health diabetes type [--] type [--] hemophilia haemophilia women's heath corporate social responsibility corporate business job career pharmaceutical pharma environment company Denmark United States USA US Novo Nordisk health diabetes type [--] type [--] hemophilia haemophilia women's heath corporate social responsibility corporate business job career pharmaceutical pharma environment company Denmark United States USA US"
YouTube Link @novonordisk 2023-10-13T11:04Z 44K followers, 240.5K engagements
"How to use FlexPen This video describes how to use FlexPen device. Novo Nordisk health diabetes type [--] type [--] hemophilia haemophilia women's heath corporate social responsibility corporate business job career pharmaceutical pharma environment company Denmark United States USA US Novo Nordisk health diabetes type [--] type [--] hemophilia haemophilia women's heath corporate social responsibility corporate business job career pharmaceutical pharma environment company Denmark United States USA US"
YouTube Link @novonordisk 2023-10-03T10:08Z 44K followers, 138.5K engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing